Quality of Life in Patients Treated with First-Line Antiretroviral Therapy Containing Nevirapine And/Or Efavirenz
A. Catalani, DB Russell, Filip Van Wanzeele(Ghent University Hospital), David Austin(Yale University), Ante Jelaska(Amsterdam UMC Location University of Amsterdam), H. Laplume(Hospital Posadas), David Éverson Uip, Carloandrea Orcese, Beatriz Grinsztejn(Fundação Oswaldo Cruz), Mark Bloch(Epworth Hospital), Andrew Gowers, R. Lattes(Unknown), Alejandro Krolewiecki, Martin Fisher(Northwell Health), Dirk Vogelaers(AZ Delta), Carlos Zala, Frank van Leth(Amsterdam Institute for Global Health and Development), Roberto Badaró(Serviço Nacional de Aprendizagem Industrial), Samira Terlizzi(Casa di Cura Villa Garda), Dick Quan, J Demonty, B van der Gucht, Martin T. Schechter(University of British Columbia), Beng Eu(The University of Melbourne), Adriana Durán, Renaat Peleman(Ghent University Hospital), Daniela Nunes(Universidade Nova de Lisboa), J Ebensrteijn, SS Coelho, Ferdinand W.N.M. Wit(Amsterdam UMC Location University of Amsterdam), Joep MA Lange(Amsterdam UMC Location University of Amsterdam), MM Moutschen, EN Netto, ML Barros, CRV Kiffer, E Bogdanowicz, Brian Conway, Des Martin(GS1 South Africa), MB Lasala, O. H. M. Leite, JH Pilotto, MH Losso, NR Roth, CT Wunsch, O Russell, A Schubach, F. Badaró, Bernard Vandercam
Cited by 28
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k